52
University College London Scale-up Issues for Whole-cell Biocatalytic Oxidation John M Woodley

Scale-up Issues for Whole-cell Biocatalytic Oxidation

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Scale-up Issues for Whole-cell Biocatalytic Oxidation

University College London

Scale-up Issues for Whole-cell Biocatalytic Oxidation

John M Woodley

Page 2: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Scale-up Issues

Scale

Productivity

Production capacity

Lab equipment Plant equipment

Page 3: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Scale-up and Implementation

Exquisite (chiral) chemistry, under mild conditions but…..

• availability of biocatalysts• integration with chemistry• productivity limitations

Page 4: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Productivity Limitations

• Substrate and product instability

• Substrate and product inhibition / toxicity• Biocatalyst instability• Non-natural substrate access into whole cells

and low rates of reaction

• Aqueous media• Integration with neighbouring operations

Page 5: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Potential Solutions

• Auxiliary phase biocatalysis– two-liquid phase – resin

• Feed and bleed• Catalyst immobilisation• Genetic engineering• Protein engineering

Page 6: Scale-up Issues for Whole-cell Biocatalytic Oxidation

BVMO

Page 7: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Model Baeyer-Villiger Reaction

O

O

H

H

O

H

H

O

+O

O2, NADPH, H+ H2O, NADP+

(-) 1(S), 5(R) 2-oxabicyclo[3.3.0]oct-6-en-3-one bicyclo[3.2.0]hept-2-en-6-one

(-) 1(R), 5(S) 3-oxabicyclo[3.3.0]oct-6-en-2-one

Alphand et al 1989 Tet Lett 30, 3663; Alphand and Furstoss 1992 J Org Chem 57, 1306

Page 8: Scale-up Issues for Whole-cell Biocatalytic Oxidation

BVMO Challenges

• Wild type host is pathogenic, contains contaminating activity and is difficult to grow

• CHMO is susceptible to oxidation and therefore unstable

• Stoichiometric quantities of NADPH are required

• Many reactions suffer from low intrinsic reaction rates and inhibition

• Reactions require molecular oxygen

Page 9: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Recombinant CHMO (pQR239)

Antibiotic – AmpicillinInducer - Arabinose

Page 10: Scale-up Issues for Whole-cell Biocatalytic Oxidation

BVMO Fermentation

0 1 2 3 4 5 6Time (h)

0

20

40

60

80

100

120

140

DO

T (%

), C

ER

, OU

R

0

200

400

600

800

1000

1200

1400

0

4

8

12

16

20

Agi

tatio

n sp

eed

(rpm

)

OD

670n

m

Arabinose induction

Page 11: Scale-up Issues for Whole-cell Biocatalytic Oxidation

1. Choice of Catalyst Form

Page 12: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Does protease inhibition improve

stability

Free enzyme

Does the R-WC suffer reactant or product toxicity

Is the enzyme the cause of the inhibition

R-WC

Does the R-WC have high enough

activity

Low enough contaminating

activity

Is the low activity due to the cell

barrier

Does the R-WC have high enough

stability

Is a R-WC available

Permeabilise

Is the enzyme the cause of the low

stability

Does the WT-WC suffer reactant or product toxicity

Is the enzyme the cause of the inhibition

WT-WC

Does the WT-WC have high enough

activity

Low enough contaminating

activity

Is the low activity due to the cell

barrier

Does the WT-WC have high enough

stability

Is the pathogenicityof the WT-WC

acceptable

Permeabilise

Is the enzyme the cause of the low

stability

Database of enzymes with

known reactions and e.e.

Does the homogenate have

high enough activity

Low enough contaminating

activity

Free enzyme

Purification

Does free enzyme suffer reactant or product inhibition

Is homogenate stability high

enough

Immobilisedenzyme

Protein engineering

Reactant or product inhibition

Protein engineering

Protein engineering

Loss of activity on immobilisation

Catalyst selection software

Page 13: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Process options

air Fermentation+

BiocatalysisPurification

Fermentation Biocatalysis Purification

Fermentation Biocatalystpreparation Biocatalysis Purification

air

airsubstrate

substrate

substrate

air

Product

Product

Product

Page 14: Scale-up Issues for Whole-cell Biocatalytic Oxidation

• Isolation procedure and losses

• Cost of immobilisation support• Number of recycles achievable• Diffusional limitations

(Thiele modulus / Damkohler number)

• Cofactor recycle

Isolated enzyme issues

Page 15: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Process Options

air Fermentation+

BiocatalysisPurification

Fermentation Biocatalysis Purificationair

airsubstrate

substrate

Product

Product

• Clean media for improved DSP

• Optimise production and use of catalyst

• Catalyst concentration independent of fermentation

Page 16: Scale-up Issues for Whole-cell Biocatalytic Oxidation

• Effects on downstream process • Side reactions and over metabolism

• Access of substrate to the enzyme• Need for molecular oxygen • Toxic effects on the host cell

Whole cell catalyst issues

Page 17: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Oxidation activities of different ketones

Ketone Enzyme/Cell

Bicyclo[3.2.0]hept-2-en-6-one 1.7 4-methylcyclohexanone 1.42-hexylcyclopentanone 5.0

Enzyme Microb Technol (2003) 32 347

Page 18: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Oxidation of bicyclo[3.2.0]hept-2-en-6-one

Catalyst %X %ee g/l/h g/l g/gdcw

Cell 85 98 0.55 04.5 02.6 Enzyme 100 98 0.47 11.0 0.38

• Trade off between downstream process (g/l) and fermentation (g/gdcw)

• Potential to overcome fermentation limit by recycle of immobilised enzyme

Biotechnol Prog (2002) 18 1039, Biotech Bioeng (2002) 78 489

Page 19: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Scale-up issues

• Process intensity• Feed-rates of reactant / media• Rates of product removal• Robustness to cope with heterogeneity• Oxygen uptake

Page 20: Scale-up Issues for Whole-cell Biocatalytic Oxidation

2. Oxygen Supply

Page 21: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Evaluation of Biocatalyst Kinetics and Stability

0

10

20

30

40

50

60

70

0 2 4 6

Ketone concentration (g.l-1)

Volu

met

ric a

ctiv

ity (U

.l-1)

OH

H

= 250 µL scale

= 1 L scale

BVMO catalysed lactone synthesis

[Doig et al (2002) Biotech. Bioeng., 80, 41]

Page 22: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Product formation during reaction

Time (min)

Pro

duct

–La

cton

e (g

/L)

0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

0 50 100 150 200 250

Page 23: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Oxygen Supply

[Catalyst]

Rat

e Oxygen supply

Reaction

Page 24: Scale-up Issues for Whole-cell Biocatalytic Oxidation

75L scale (10 g/L dcw)

0 1 2 3 4 5 6Time (h)

0

20

40

60

80

100

120

140

DO

T (%

)

0

200

400

600

800

1000

1200

1400

0

4

8

12

16

20

Agi

tatio

n sp

eed

(rpm

)

OD

670n

m

7 8 9 100

1

2

3

4

5

6

Ket

one

/ Lac

tone

(g/L

)

biomass CHMO reaction

Page 25: Scale-up Issues for Whole-cell Biocatalytic Oxidation

75L scale (5 g/L dcw)

0 1 2 3 4 5 6Time (h)

0

20

40

60

80

100

120

140

DO

T (%

)

0

200

400

600

800

1000

1200

1400

0

4

8

12

16

20

Agi

tatio

n sp

eed

(rpm

)

OD

670n

m

0 1 2 30

1

2

3

4

5

6

Ket

one

/ Lac

tone

(g/L

)

biomass CHMO reaction

Page 26: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Biomass (g/L)

Process limitationsIn

itial

Pro

duct

ion

rate

(g/L

.h)

0

1.0

2.0

3.0

6.0

4.0

5.0

max specific activity(0.65g/g.h)

0 2 4 6 8 10 12

SF/1.5L

1.5LSF75L

1.5LSF75L

Page 27: Scale-up Issues for Whole-cell Biocatalytic Oxidation

% Oxygen in air

Enriched air supplyIn

itial

Pro

duct

ion

rate

(g/L

.h)

0

1.0

2.0

3.0

6.0

4.0

5.0

0 20 40 60 80 100

Page 28: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Biomass (g/L)

Process limitationsIn

itial

Pro

duct

ion

rate

(g/L

.h)

0

1.0

2.0

3.0

6.0

4.0

5.0

max specific activity(0.65g/g.h)

0 2 4 6 8 10 12

SF/1.5L

1.5LSF75L

1.5L – 10%O2

1.5L – 21%O2

1.5L – 40%O2

1.5L – 60%O2

SF75L In

crea

se in

Oxy

gen

Page 29: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Whole Cell Reaction Model

Biomass concentration

Oxy

gen

dem

and

Metabolism

Metabolism+ Reaction

supplyO2

O2 limitation

O2 limitation

Page 30: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Time (min)

Productivity LimitationsOxygen limitation

(Rate)Biocatalyst lifespan

(Time)

Product Inhibition(concentration)

Pro

duct

–La

cton

e (g

/L)

0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0

4.5

Page 31: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Biocatalyst concentration

Time (min)

Pro

duct

–La

cton

e (g

/L)

0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0

0 100 200 300 400 500

0.2 g/L

1.0 g/L

3.0 g/L5.0 g/L

4.5

7.0 g/L

[Cel

l]

Page 32: Scale-up Issues for Whole-cell Biocatalytic Oxidation

3. Product Concentration

Page 33: Scale-up Issues for Whole-cell Biocatalytic Oxidation

O

O

O

Resin Based Reactor Concept

Page 34: Scale-up Issues for Whole-cell Biocatalytic Oxidation

air

VCYCLE

.

fixed bed of adsorbent

glycerol

biocatalyst/cell exchange

pH-sensorO -sensor2

1M H PO , 4M KOH3 4

Recycle Reactor with Fixed Bed

entry fermenter

outlet fermenter

Page 35: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Oxidation of bicyclo[3.2.0]hept-2-en-6-one

Catalyst %X %ee g/l/h g/l g/gdcw

Cell 85 98 0.55 04.5 02.6 Enzyme 100 98 0.47 11.0 0.38

Cell* 100 98 1.02 20.0 3.40

• Integration with ISPR is critical

Page 36: Scale-up Issues for Whole-cell Biocatalytic Oxidation

4. Process Integration

Page 37: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Bioconversion time

O2 Stability

[Product]

Prod

uct c

once

ntra

tion

[Cell]

Effect of cell concentration

Page 38: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Catalyst Concentration

• Determines interaction with fermentation

• Determines what is limiting productivity in the reactor– catalyst preparation – conversion– downstream processing

Page 39: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Catalyst Preparation

Fermentation Dewater Biocatalysis

Fermentation

Fermentation

Dilution Biocatalysis

Biocatalysis

Concentration

Dilution

Direct

Page 40: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Catalyst Concentration Map

AB

[Catalyst] in reaction

[Catalyst]in

fermentation

ineffective

ineffective

ineffective

Expression

Dilution Concentration

Direct

A – Rate limitedB – Product / Catalyst stability limited

Page 41: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Process Drivers

Catalyst Production

Conversion Downstream Processing

Page 42: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Reaction profiles

AB

C

Time

[Product]

Page 43: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Process Metrics

Metric Cost

g/g catalyst productiong/l/h conversiong/l downstream process

Page 44: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Regime analysis

A B

[Catalyst]

Metric

Stability Product Ratelimited limited limited

Cg/g

g/l/hr

g/l

Page 45: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Process Mapping

Trans I Chem E C (2002) 80 51

Page 46: Scale-up Issues for Whole-cell Biocatalytic Oxidation

CHMO Available….

Page 47: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Products available….

Page 48: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Productivity Targets

gproduct/L

g pro

duct/g

biom

ass

Optimise [Cell]and oxygen

100

10

1.0

0.10 5 10 15 20 25 30

ISPR

Optimise [Cell]and oxygen+ ISPR

Page 49: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Conclusions

• Recombinant Escherichia coli containing CHMO – 300 L scale• Conversion using CHMO – 200 L and 50 L scale / 1 Kg• Oxygen supply – modelled and understood limitations• Product inhibition – modelled and implementation of ISPR

• Scalable process using whole cell CHMO

Page 50: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Future

• Rapid methods of removing product

• Adequate means of oxygen supply

• Modelling for process analysis

• Isolation of product

• Improving stability of whole cells

Page 51: Scale-up Issues for Whole-cell Biocatalytic Oxidation

Acknowledgements

• Jenny Littlechild, Exeter, UK• John Ward, UCL, UK• Dick Janssen, Groningen, NL• Marcel Wubbolts, DSM, NL

• Giacomo Carrea, CNR Milan, IT• Roland Wohlgemuth, Sigma-Aldrich Chemie, CH• Roger Cripps, Consultant, UK• Roland Furstoss, CNRS Marseille, FR

• European Commission• BIO4-CT98-00267• QLK3-CT01-00403

Page 52: Scale-up Issues for Whole-cell Biocatalytic Oxidation

EC BVMO Programme